ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Obesity
Diabetic Foot
Foot Ulcer
Overweight

Diabetes trials near Warszawa, Mazowieckie, POL:

Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity (SINT1A)

months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...

Active, not recruiting
Diabetes Mellitus, Type 1
Dietary Supplement: Placebo
Dietary Supplement: B. infantis
Helmholtz Zentrum München

Warsaw, Poland and 7 other locations

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Warsaw, Poland and 59 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Enrolling
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Warsaw, Poland and 186 other locations

evaluate the efficacy, safety and pharmacokinetic (PK) properties of CPL207280 after multiple (14 days) administration in patients with type 2 diabetes...

Enrolling
Type 2 Diabetes
Drug: Placebo
Drug: CPL207280

Phase 2

Celon Pharma

Kajetany, Nadarzyn, Poland

The primary purpose of this study is to evaluate the efficacy of medical cannabis aerosol containing 0.25, 0.5, 1.0 milligrams (mg) delta (Δ)9-tetrah...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Medical Cannabis
Drug: Placebo

Phase 2

Syqe Medical

Warszawa, Mazowieckie, Poland and 37 other locations

This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...

Active, not recruiting
Type 2 Diabetes
Drug: Semaglutide
Drug: Placebo

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 46 other locations

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes...

Enrolling
Type 2 Diabetes
Drug: LY3457263
Drug: Placebo

Phase 2

Lilly
Lilly

Warsaw, Poland and 55 other locations

help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doct...

Enrolling
Type 2 Diabetes (T2D)
Drug: Placebo (NNC0487-0111 oral)
Drug: NNC0487-0111 oral

Phase 2

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 111 other locations

The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly co...

Enrolling
Diabetes Mellitus, Type 1
Drug: Insulin glargine
Drug: Insulin icodec

Phase 3

Novo Nordisk
Novo Nordisk

Warsaw, Poland and 173 other locations

This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2D) and overweight ...

Active, not recruiting
Type 2 Diabetes
Chronic Kidney Disease
Drug: Cagrilintide
Drug: Semaglutide

Phase 2

Novo Nordisk
Novo Nordisk

Warsaw, Poland and 120 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems